Selective S1P1/Edg1 receptor agonists

Details for Australian Patent Application No. 2003216054 (hide)

Owner Merck & Co., Inc.

Inventors Rosen, Hugh; Li, Zhen; Hajdu, Richard; Doherty, George A; Mills, Sander G; Scolnick, Edward M; Forrest, Michael J; Hale, Jeffrey J; Mandala, Suzanne M

Agent Spruson & Ferguson

Pub. Number AU-B-2003216054

PCT Number PCT/US03/01120

PCT Pub. Number WO2003/061567

Priority 60/362,566 07.03.02 US; 60/349,991 18.01.02 US; 60/382,933 23.05.02 US

Filing date 14 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 4 January 2007

International Classifications

A61K 31/00 (2006.01)

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/362,566 07.03.02 US; 60/349,991 18.01.02 US; 60/382,933 23.05.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003216054

4 January 2007 Application Accepted

  Published as AU-B-2003216054

3 May 2007 Standard Patent Sealed

12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003216055-CONFIGURATION ENABLING RAPID FUEL CELL POWER FROM SUBFREEZING INITIAL CONDITION

2003216053-GUANIDINO COMPOUNDS